Since GM-CSF was also reported to increase the ability of microglia to phagocytose myelin (Smith, 1993) it is tempting to speculate that GM-CSF-activated microglia might play a role in demyelinating diseases. This evidence concerns the gene CSF2 and demyelinating disease.